复杂的林纳与β-环氧德克斯改善抗高血压活性:药理动力学和药理动力学见解
Samuel Camargo1,2, Carla Medeiros3, Liliane Silva2
1Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador 41745-715, Brazil.
Pharmaceuticals (Basel, Switzerland)
|January 28, 2026
概括
(-) - 林醇 (LIN/β-CD) 的β-环氧素复合物显著提高了其生物可用性,并增强了其抗高血压和心脏保护作用,用于控制动脉高血压.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
- 自然产品 化学 化学
背景情况:
- 动脉高血压 (AH) 是一个全球性的健康问题,治疗选择有限,心血管风险高.
- 植物衍生化合物,如 (-) - 林醇 (LIN),显示出AH管理的潜力.
- 溶解度差和生物利用度低阻碍了LIN的临床使用.
研究的目的:
- 在自发高血压大鼠 (SHR) 中评估自由LIN及其与β-cyclodextrin (LIN/β-CD) 合并复合物的慢性心血管影响.
- 评估LIN/β-CD对药理动力学,血压,心脏重塑和血管功能的影响.
- 确定LIN/β-CD作为高血压的口服配方的安全性和有效性.
主要方法:
- 在老鼠中对LIN和LIN/β-CD的药理动力学分析.
- 在SHR和Wistar大鼠中,急性和慢性给予LIN和LIN/β-CD.
- 评估血压,心脏质量指数,血管反应能力和组织学变化.
主要成果:
- LIN/β-CD复合增加了LIN的生物可用性~20倍,并延长了循环时间.
- 口服LIN/β-CD在SHR中表现出优越且持续的抗高血压效果,与自由LIN相比.
- LIN/β-CD降低了心脏质量指数,改善了血管放松,减少了血管收缩,而不会造成损伤.
结论:
- 该LIN/β-CD复合物显著提高了LIN的药理动力学特征和治疗疗效.
- LIN/β-CD具有强大的抗高血压和心脏保护作用,改善动脉形态和血管功能.
- 这些发现支持LIN/β-CD作为安全有效的高血压口服治疗的翻译潜力.
相关概念视频
Pharmacodynamics: Overview and Principles
3.0K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
3.0K
Measurement of Bioavailability: Pharmacodynamic Methods
624
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
624
Protein Complex Assembly
16.7K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Many viruses self-assemble into a fully functional unit using the infected host cell to...
16.7K
Antihypertensive Drugs: Vasodilators
2.2K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.2K
Antihypertensive Drugs: Action of Diuretics
2.4K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.4K
Pharmacodynamics in Geriatric Patients: Effects of Age
202
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
202


